The changing spectrum of drug-induced myopathies

por Mastaglia, Frank L.
Publicado 2020

Plasticity in neurological disorders and challenges for noninvasive brain stimulation (NBS)

por Thickbroom, Gary W, Mastaglia, Frank L
Publicado 2009

Cationic Arginine-Rich Peptides (CARPs): A Novel Class of Neuroprotective Agents With a Multimodal Mechanism of Action

por Meloni, Bruno P., Mastaglia, Frank L., Knuckey, Neville W.
Publicado 2020

Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era

por Li, Dunhui, Mastaglia, Frank L., Fletcher, Sue, Wilton, Steve D.
Publicado 2020

Proteomic analysis of cortical neuronal cultures treated with poly-arginine peptide-18 (R18) and exposed to glutamic acid excitotoxicity

por MacDougall, Gabriella, Anderton, Ryan S., Mastaglia, Frank L., Knuckey, Neville W., Meloni, Bruno P.
Publicado 2019

Assessment of the safety of the cationic arginine-rich peptides (CARPs) poly-arginine-18 (R18 and R18D) in ex vivo models of mast cell degranulation and red blood cell hemolysis

por Edwards, Adam B., Mastaglia, Frank L., Knuckey, Neville W., Yip, Kwok-Ho, Meloni, Bruno
Publicado 2022

Intronic NEFH variant is associated with reduced risk for sporadic ALS and later age of disease onset

por Theunissen, Frances, Anderton, Ryan S., Mastaglia, Frank L., James, Ian, Bedlack, Richard, Akkari, P. Anthony
Publicado 2022

Impact of Gastrointestinal Symptoms on Health-Related Quality of Life in an Australian Parkinson's Disease Cohort

por Kenna, Jade E., Bakeberg, Megan C., Abonnel, Maddison Y., Mastaglia, Frank L., Anderton, Ryan S.
Publicado 2022

Late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (MADD): case reports and epidemiology of ETFDH gene mutations

por Chen, Wei, Zhang, Youqiao, Ni, Yifeng, Cai, Shaoyu, Zheng, Xin, Mastaglia, Frank L., Wu, Jingshan
Publicado 2019

Poly-arginine-18 (R18) Confers Neuroprotection through Glutamate Receptor Modulation, Intracellular Calcium Reduction, and Preservation of Mitochondrial Function

por MacDougall, Gabriella, Anderton, Ryan S., Trimble, Amy, Mastaglia, Frank L., Knuckey, Neville W., Meloni, Bruno P.
Publicado 2020

Targeted Molecular Therapeutics for Parkinson's Disease: A Role for Antisense Oligonucleotides?

por Li, Dunhui, Mastaglia, Frank L., Yau, Wai Yan, Chen, Shengdi, Wilton, Steve D., Akkari, Patrick A.
Publicado 2022

Antisense Oligonucleotide Induction of Progerin in Human Myogenic Cells

por Luo, Yue-Bei, Mitrpant, Chalermchai, Adams, Abbie M., Johnsen, Russell D., Fletcher, Sue, Mastaglia, Frank L., Wilton, Steve D.
Publicado 2014

Demographic and Clinical Predictors of Trait Impulsivity in Parkinson's Disease Patients

por Riley, Maddeson, Bakeberg, Megan, Byrnes, Michelle, Jefferson, Alexa, Ghosh, Soumya, Stell, Rick, Mastaglia, Frank L., Hince, Dana, Anderton, Ryan S.
Publicado 2018

TOMM40‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease

por Bakeberg, Megan C., Gorecki, Anastazja M., Pfaff, Abigail L., Hoes, Madison E., Kõks, Sulev, Akkari, P. Anthony, Mastaglia, Frank L., Anderton, Ryan S.
Publicado 2021

Changes in the Gut Microbiome and Predicted Functional Metabolic Effects in an Australian Parkinson’s Disease Cohort

por Kenna, Jade E., Chua, Eng Guan, Bakeberg, Megan, Tay, Alfred, McGregor, Sarah, Gorecki, Anastazja, Horne, Malcolm, Marshall, Barry, Mastaglia, Frank L., Anderton, Ryan S.
Publicado 2021

Quality of life implications for elevated trait impulsivity in people with Parkinson’s disease

por Jeyadevan, Ashani, Bakeberg, Megan, Byrnes, Michelle, Kenna, Jade, McGregor, Sarah, Ghosh, Soumya, Horne, Malcom K., Stell, Rick, Evans, Tess, Mastaglia, Frank L., Anderton, Ryan
Publicado 2023

Trait Impulsivity Is Independent of Mild Cognitive Impairment in a Parkinson's Disease Cohort

por Jeyadevan, Ashani, Bakeberg, Megan C., Byrnes, Michelle, Kenna, Jade, Ghosh, Soumya, Stell, Rick, Walters, Sue, Evans, Tess, McGregor, Sarah, Horne, Malcolm, Mastaglia, Frank L., Anderton, Ryan S.
Publicado 2019

Altered Gut Microbiome in Parkinson’s Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model

por Gorecki, Anastazja M., Preskey, Leah, Bakeberg, Megan C., Kenna, Jade E., Gildenhuys, Christi, MacDougall, Gabriella, Dunlop, Sarah A., Mastaglia, Frank L., Akkari, P. Anthony, Koengten, Frank, Anderton, Ryan S.
Publicado 2019

The TOMM40 ‘523’ polymorphism in disease risk and age of symptom onset in two independent cohorts of Parkinson’s disease

por Bakeberg, Megan C., Hoes, Madison E., Gorecki, Anastazja M., Theunissen, Frances, Pfaff, Abigail L., Kenna, Jade E., Plunkett, Kai, Kõks, Sulev, Akkari, P. Anthony, Mastaglia, Frank L., Anderton, Ryan S.
Publicado 2021

Elevated Serum Homocysteine Levels Have Differential Gender-Specific Associations with Motor and Cognitive States in Parkinson's Disease

por Bakeberg, Megan C., Jefferson, Alexa, Riley, Maddeson, Byrnes, Michelle, Ghosh, Soumya, Mastaglia, Frank L., Horne, Malcom K., McGregor, Sarah, Stell, Rick, Kenna, Jade, Walters, Sue, Hince, Dana, Anderton, Ryan S.
Publicado 2019